99mTc sestamibi imaging - can it be a useful substitute for hepatobiliary scintigraphy in infantile jaundice?

@article{Sadeghi200999mTcSI,
  title={99mTc sestamibi imaging - can it be a useful substitute for hepatobiliary scintigraphy in infantile jaundice?},
  author={Ramin Sadeghi and Hamidreza Kianifar and Vahid Reza Dabbagh Kakhki and Seyyed Rasoul Zakavi and Kianoush Ansari},
  journal={Nuklearmedizin. Nuclear medicine},
  year={2009},
  volume={48 3},
  pages={
          100-3
        }
}
AIM Hepatobiliary scintigraphy is an integral part in the diagnostic work-up of the neonatal cholestasis syndrome. However, less than optimal specificity is its major disadvantage. Differentiation between biliary atresia and neonatal hepatitis is nearly impossible in some cases with poor hepatocellular function. 99mTc sestamibi (MIBI) is a cationic lipophilic agent which is a substrate of P-glycoprotein. This glycoprotein is normally expressed in biliary canalicular surfaces of hepatocytes… 
3 Citations
Accuracy of hepatobiliary scintigraphy for differentiation of neonatal hepatitis from biliary atresia: systematic review and meta-analysis of the literature
TLDR
It is concluded that hepatobiliary scintigraphy using IDA derivatives can be very useful for diagnostic work-up of neonatal cholestasis and non-imaging methods seem to be promising and warrant further validation.
Application of ursodeoxycholic acid in hepatobiliary scintigraphy for neonatal hyperbilirubinemia: Comparison with phenobarbital
TLDR
Ursodeoxycholic acid is a safe and efficient drug for pre-treatment of patients with neonatal cholestasis syndrome who are going to undergo hepatobiliary scintigraphy, which has fewer complications and is more efficient than phenobarbital.
Drug augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: what does the evidence point to?
  • R. Sadeghi
  • Medicine
    Nuclear medicine communications
  • 2015
TLDR
The study by Malik and colleagues was a unique randomized controlled trial on cholestatic infants that used nonexcretory nonaugmented hepatobiliary scintigraphy to compare phenobarbital (PB) and ursodexoycholic (UDC).

References

SHOWING 1-10 OF 27 REFERENCES
Hepatobiliary scintigraphy in children.
  • H. Nadel
  • Medicine
    Seminars in nuclear medicine
  • 1996
Hepatobiliary scintigraphy with technetium-99m disofenin in the evaluation of neonatal cholestasis.
TLDR
It is recommended that cholescintigraphy should not be routinely used in evaluating neonatal cholestasis, especially if it delays surgical intervention.
Ursodeoxycholic acid-augmented hepatobiliary scintigraphy in the evaluation of neonatal jaundice.
TLDR
Pretreatment with UDCA significantly improves the specificity of hepatobiliary scintigraphy in ruling out extrahepatic biliary atresia as a cause of prolonged neonatal jaundice.
The use of hepatocyte extraction fraction to evaluate neonatal cholestasis.
TLDR
A single determination of HEF is of no value in assessing synthetic liver function, specific diagnoses, and outcomes in patients with neonatal cholestasis.
Betamethasone in plus phenobarbitone prior to hepatobiliary scintigraphy increases diagnostic accuracy in infants with jaundice
TLDR
Addition of BM increases the diagnostic accuracy of the HBS and this would lead to decreased need for peroperative cholangiography to distinguish NH from EHBA.
Outcome of hepatobiliary scanning in neonatal hepatitis syndrome.
TLDR
Hepatobiliary scanning requires cautious interpretation, and nondraining scans may indicate severe neonatal hepatitis or the presence of interlobular bile duct paucity.
Biliary Atresia and Neonatal Hepatobiliary Scintigraphy
Hepatobiliary scintigraphy using Tc-99m diethyl IDA was performed on 14 jaundiced neonates. It aided greatly the differential diagnosis between neonatal hepatitis and biliary atresia. Limitations in
Duodenal Tube Test in the Diagnosis of Biliary Atresia
TLDR
The data obtained from this series validate the DTT as a useful clinical tool for the differential diagnosis of the infant with cholestasis, particularly for indicating laparotomy and cholangiogram to substantiate BA.
...
1
2
3
...